Articol

Sanofi to invest 350 million euros in Canada vaccine facility

Sanofi to invest 350 million euros in Canada vaccine facility

The new investment will be used for financing the construction of a new modern vaccine manufacturing facility


French healthcare group Sanofi is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, Reuters reports. 


The new investment will be used for financing the construction of a new modern vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.
The new facility would allow its Sanofi Pasteur division to meet the growing demand of five-component acellular pertussis (5-acP) antigen, the company announced.


Sanofi sealed two major takeovers at the start of 2018, buying hemophilia specialist Bioverativ for $11.6 billion and acquiring Ablynx, which is developing a prized experimental drug for a rare blood disorder, for 3.9 billion euros ($4.8 billion).

Comentarii